The Discounted Cash Flow (DCF) valuation of Inovio Pharmaceuticals Inc (INO) is (99.96) USD. With the latest stock price at 2.13 USD, the upside of Inovio Pharmaceuticals Inc based on DCF is -4792.9%.
Based on the latest price of 2.13 USD and our DCF valuation, Inovio Pharmaceuticals Inc (INO) is a sell. selling INO stocks now will result in a potential gain of 4792.9%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 5.3% - 7.5% | 6.4% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (696.95) - (55.41) | (99.96) |
| Upside | -32820.6% - -2701.3% | -4792.9% |